Stock Research for DRRX

DRRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

DRRX Stock Chart & Research Data

The DRRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DRRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


DRRX Due diligence Resources & Stock Charts

The DRRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DRRX Detailed Price Forecast - CNN Money CNN View DRRX Detailed Summary - Google Finance
Yahoo View DRRX Detailed Summary - Yahoo! Finance Zacks View DRRX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View DRRX Trends & Analysis - Trade-Ideas Barrons View DRRX Major Holders - Barrons
NASDAQ View DRRX Call Transcripts - NASDAQ Seeking View DRRX Breaking News & Analysis - Seeking Alpha
Spotlight View DRRX Annual Report - CompanySpotlight.com OTC Report View DRRX OTC Short Report - OTCShortReport.com
TradeKing View DRRX Fundamentals - TradeKing Charts View DRRX SEC Filings - Bar Chart
WSJ View Historical Prices for DRRX - The WSJ Morningstar View Performance/Total Return for DRRX - Morningstar
MarketWatch View the Analyst Estimates for DRRX - MarketWatch CNBC View the Earnings History for DRRX - CNBC
StockMarketWatch View the DRRX Earnings - StockMarketWatch MacroAxis View DRRX Buy or Sell Recommendations - MacroAxis
Bullish View the DRRX Bullish Patterns - American Bulls Short Pains View DRRX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View DRRX Stock Mentions - StockTwits PennyStocks View DRRX Stock Mentions - PennyStockTweets
Twitter View DRRX Stock Mentions - Twitter Invest Hub View DRRX Investment Forum News - Investor Hub
Yahoo View DRRX Stock Mentions - Yahoo! Message Board Seeking Alpha View DRRX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for DRRX - SECform4.com Insider Cow View Insider Transactions for DRRX - Insider Cow
CNBC View DRRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DRRX - OTC Markets
Yahoo View Insider Transactions for DRRX - Yahoo! Finance NASDAQ View Institutional Holdings for DRRX - NASDAQ


Stock Charts

FinViz View DRRX Stock Insight & Charts - FinViz.com StockCharts View DRRX Investment Charts - StockCharts.com
BarChart View DRRX Stock Overview & Charts - BarChart Trading View View DRRX User Generated Charts - Trading View




Latest Financial News for DRRX


DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
Posted on Monday April 01, 2024

DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript March 27, 2024 DURECT Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.36. DRRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the DURECT Corporation Full […]


Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
Posted on Wednesday March 27, 2024

DURECT (DRRX) delivered earnings and revenue surprises of 25% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?


DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Posted on Wednesday March 27, 2024

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update.


DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
Posted on Wednesday March 20, 2024

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer, today announced that the company will report its fourth quarter and full year 2023 financial results on Wednesday, March 27, 2024. Management will also host a conference call and webcast with investors to discuss financial results and provide a corporate update a


Stock Market & Investing Books

Enter a stock symbol to view the stock details.